MLM changes
Pick any two versions below to diff them.
- Price
- $524.13 → $500.74(−4.5%)
- Valuation
- added: This section holds two cross-checks that are our own work. Neither of them is the analysts' intrinsic value. Aggregates price history. Martin Marietta reports the average selling price of its aggregates per ton. It was $10.33 in 2012, $13.46 in 2017, $14.77 in 2020, $19.84 in 2023 and $23.30 in 2025. The 2025 price is 2.26 times the 2012 price, a rise of 6.5% a year. US consumer prices (CPI-U, not seasonally adjusted, annual averages) rose 1.40 times in the same years, which is 2.6% a year. So the price per ton rose 1.6 times after inflation. Our figures start in 2012, because the filings that we read give dollar prices per ton from that year and only percent changes before it. In nine months of 2026, the price was $22.85 per ton, down 2% from $23.37 a year earlier. The company expects a fall of 2% to 3% for the full year. For 2025, the CPI average uses the 11 months that the government published. Free cash flow per share as debt falls. This is our model, not a company forecast. Free cash flow here is adjusted EBITDA less interest, cash tax and capital spending, before dividends. The assumptions are as follows. Adjusted EBITDA is $3,150 million in 2027, up about 6% from the pro forma 2026 figure, and then it grows 4% a year. Interest is 4.65% of net debt, which is the rate that the guidance for the fourth quarter of 2026 implies. Tax is 21% of EBITDA less depreciation and interest, with depreciation of $950 million that grows 3% a year. Capital spending is $750 million and grows 3% a year. Dividends are $240 million a year, and there are no buybacks or acquisitions. The share count stays at 71.1 million, and net debt starts at $12,683 million. Free cash flow is then about $1,472 million in 2027, or $20.7 per share, $1,600 million in 2028 ($22.5), $1,737 million in 2029 ($24.4) and $1,882 million in 2030 ($26.5). Net debt falls to about $11.5 billion at the end of 2027, which is 3.6 times EBITDA. It is about $10.1 billion in 2028 (3.1 times), $8.6 billion in 2029 (2.5 times) and $7.0 billion in 2030 (2.0 times). If EBITDA stays near the 2026 pro forma figure, the path is lower and debt falls more slowly. As of Nov 21, 2026.
- Private market value
- added: CRH's 2026 deal for Arcosa (11.5 times EBITDA) and Martin Marietta's own price for LNA (about 17 times). On June 22, 2026, CRH agreed to buy Arcosa for $150 a share in cash. CRH gave an enterprise value of about $8.5 billion, which is 11.5 times its expected 2026 adjusted EBITDA, with cost savings of $175 million that CRH expects by year three. Arcosa also makes infrastructure products, so this is not a pure aggregates price. We apply 11.5 times to a pro forma 2026 adjusted EBITDA of about $2,960 million for Martin Marietta. This figure is our assumption. It is the guidance midpoint of $2,475 million plus about $483 million for LNA before the closing. The enterprise value is about $34.0 billion. We take away net debt of $12,683 million at September 30, 2026 and divide by 71,118,485 shares. This gives about $300 per share. Martin Marietta paid about 17 times LNA's EBITDA of about $760 million. At 17 times, the same steps give about $529 per share. These are values from deal multiples, not forecasts. The CRH multiple counts cost savings, and our Martin Marietta figure does not. As of Nov 21, 2026.